Company: Pharmstandard
Business: A Russian pharmaceutical company. They are producing and selling around 250 different pharmaceutical products. They have eight production lines of which six are already complying to the EU GMP regulations and the remaining two will be converted before the end of 2014. They already have a foot in Cyprus (EU) which means they have the possibility to step into Europe.
Active: They are currently focused on Russia, Ukraine and have, as mentioned, one foot in Cyprus.
P/E: 4.7
